αα2C-adrenoceptor modulators: a patent review

Author： Quaglia Wilma   Del Bello Fabio   Giannella Mario   Piergentili Alessandro   Pigini Maria  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.4, 2011-04, pp. : 455-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR2 modulators: a patent review (2009 – 2013)

By Dwyer Michael P   Yu Younong  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 519-534

Informa Healthcare

Access to resources Recommend Favorite

The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity

By Jahnsen Jan   Uhlén Staffan  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 12, 2013-12 ,pp. : 1031-1040

Springer Publishing Company

Access to resources Recommend Favorite

Integrin modulators: a patent review

By Kapp Tobias G   Rechenmacher Florian   Sobahi Tariq R   Kessler Horst  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1273-1295

Informa Healthcare

Access to resources Recommend Favorite

PTEN modulators: a patent review

By Boosani Chandra S   Agrawal Devendra K  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 569-580

Informa Healthcare

Access to resources Recommend Favorite

5-HT2C receptor modulators: a patent survey

By Lee Junwon   Jung Myung Eun   Lee Jinhwa  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1429-1455

Informa Healthcare

Access to resources Recommend Favorite